These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 35699766)

  • 1. Prophylactic Enoxaparin Against Catheter-Associated Thrombosis in Postoperative Cardiac Children: An Interrupted Time Series Analysis.
    Centers GI; Hege KM; Nitu ME; Cristea IA; Yabrodi M; Schade Willis TM; Bhai H; Faustino EVS
    Pediatr Crit Care Med; 2022 Oct; 23(10):774-783. PubMed ID: 35699766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-Dependent Heterogeneity in the Efficacy of Prophylaxis With Enoxaparin Against Catheter-Associated Thrombosis in Critically Ill Children: A Post Hoc Analysis of a Bayesian Phase 2b Randomized Clinical Trial.
    Faustino EVS; Raffini LJ; Hanson SJ; Cholette JM; Pinto MG; Li S; Kandil SB; Nellis ME; Shabanova V; Silva CT; Tala JA; McPartland T; Spinella PC; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Crit Care Med; 2021 Apr; 49(4):e369-e380. PubMed ID: 33566465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of prophylactic enoxaparin dosing recommendations to achieve targeted anti-factor Xa concentrations in children with CHD.
    Israel EN; Thomas CA; Mastropietro CW
    Cardiol Young; 2018 May; 28(5):715-718. PubMed ID: 29490713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Catheter-Related Arterial and Venous Thrombosis After Enoxaparin Therapy in Neonates and Infants With Congenital Heart Disease.
    Saini A; Cavalcante R; Crisanto LA; Sasaki J
    Pediatr Crit Care Med; 2021 Dec; 22(12):1042-1049. PubMed ID: 34554133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Early Prophylaxis Against Catheter-Associated Thrombosis in Critically Ill Children: A Bayesian Phase 2b Randomized Clinical Trial.
    Faustino EVS; Shabanova V; Raffini LJ; Kandil SB; Li S; Pinto MG; Cholette JM; Hanson SJ; Nellis ME; Silva CT; Chima R; Sharathkumar A; Thomas KA; McPartland T; Tala JA; Spinella PC;
    Crit Care Med; 2021 Mar; 49(3):e235-e246. PubMed ID: 33372745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Prophylactic Enoxaparin Against Venous Thromboembolism in Hospitalized Children.
    Bennett E; Delgado-Corcoran C; Pannucci CJ; Wilcox R; Heyrend C; Faustino EV
    Hosp Pediatr; 2022 Jun; 12(6):617-625. PubMed ID: 35531629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic anticoagulation in children receiving home parenteral nutrition.
    Nagelkerke SCJ; Schoenmaker MHA; Tabbers MM; Benninga MA; van Ommen CH; Gouw SC
    JPEN J Parenter Enteral Nutr; 2022 Jul; 46(5):1036-1044. PubMed ID: 34719795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enoxaparin Reduces Catheter-associated Venous Thrombosis After Infant Cardiac Surgery.
    Swartz MF; Hutchinson DJ; Stauber SD; Taillie ER; Alfieris GM; Cholette JM
    Ann Thorac Surg; 2022 Sep; 114(3):881-888. PubMed ID: 34062124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Impact of a Standardized Risk-Stratified Thromboprophylaxis Protocol for Multisystem Inflammatory Syndrome in Children.
    Rajput RV; Sharron MP; Pavuluri P; Hansen H; Ansusinha E; DeBiasi R; Majumdar S; Diab Y
    J Pediatr; 2023 Nov; 262():113624. PubMed ID: 37473994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Xa-guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients.
    Singer GA; Riggi G; Karcutskie CA; Vaghaiwalla TM; Lieberman HM; Ginzburg E; Namias N; Lineen EB
    J Trauma Acute Care Surg; 2016 Dec; 81(6):1101-1108. PubMed ID: 27488490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
    ; Sadeghipour P; Talasaz AH; Rashidi F; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Jamalkhani S; Khalili H; Yadollahzadeh M; Riahi T; Rezaeifar P; Tahamtan O; Matin S; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Bakhshandeh H; Amin A; Rafiee F; Baghizadeh E; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Dobesh PP; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Bikdeli B
    JAMA; 2021 Apr; 325(16):1620-1630. PubMed ID: 33734299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter-Related Venous Thrombosis in Hospitalized Pediatric Patients with Inflammatory Bowel Disease: Incidence, Characteristics, and Role of Anticoagulant Thromboprophylaxis with Enoxaparin.
    Diamond CE; Hennessey C; Meldau J; Guelcher CJ; Guerrera MF; Conklin LS; Sharma KV; Diab YA
    J Pediatr; 2018 Jul; 198():53-59. PubMed ID: 29628414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Xa guided enoxaparin dose adjustment improves pharmacologic deep venous thrombosis prophylaxis in burn patients.
    Cronin BJ; Godat LN; Berndtson AE; Pham A; Kolan S; Box K; Lee JG; Costantini TW
    Burns; 2019 Jun; 45(4):818-824. PubMed ID: 30827851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Xa activity after enoxaparin prophylaxis in hospitalized patients weighing less than fifty-five kilograms.
    Rojas L; Aizman A; Ernst D; Acuña MP; Moya P; Mellado R; Cerda J
    Thromb Res; 2013; 132(6):761-4. PubMed ID: 24521789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight heparin in thrombotic disease in children and adolescents.
    Punzalan RC; Hillery CA; Montgomery RR; Scott CA; Gill JC
    J Pediatr Hematol Oncol; 2000; 22(2):137-42. PubMed ID: 10779027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trauma patients with lower extremity and pelvic fractures: Should anti-factor Xa trough level guide prophylactic enoxaparin dose?
    Dhillon NK; Smith EJT; Gillette E; Mason R; Barmparas G; Gewertz BL; Ley EJ
    Int J Surg; 2018 Mar; 51():128-132. PubMed ID: 29367044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enoxaparin therapy for arterial thrombosis in infants with congenital heart disease.
    Bontadelli J; Moeller A; Schmugge M; Schraner T; Kretschmar O; Bauersfeld U; Bernet-Buettiker V; Albisetti M
    Intensive Care Med; 2007 Nov; 33(11):1978-84. PubMed ID: 17554520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enoxaparin use in the neonatal intensive care unit: experience over 8 years.
    Malowany JI; Knoppert DC; Chan AK; Pepelassis D; Lee DS
    Pharmacotherapy; 2007 Sep; 27(9):1263-71. PubMed ID: 17723080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
    Barco S; Bingisser R; Colucci G; Frenk A; Gerber B; Held U; Mach F; Mazzolai L; Righini M; Rosemann T; Sebastian T; Spescha R; Stortecky S; Windecker S; Kucher N
    Trials; 2020 Sep; 21(1):770. PubMed ID: 32907635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose adjusting enoxaparin is necessary to achieve adequate venous thromboembolism prophylaxis in trauma patients.
    Costantini TW; Min E; Box K; Tran V; Winfield RD; Fortlage D; Doucet J; Bansal V; Coimbra R
    J Trauma Acute Care Surg; 2013 Jan; 74(1):128-33; discussion 134-5. PubMed ID: 23271087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.